This provider's $3.4M in total Medicare payments ranks in the 99th percentile of Hematopoietic Cell Transplantation and Cellular Therapy providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 80% in 2017
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $355.38 | $111.47 | 3.19x | $243.91 | $280.3K | 5.5K | 1.8K |
| 2015 | $331.38 | $115.68 | 2.86x | $215.70 | $235.2K | 5.7K | 1.9K |
| 2016 | $208.21 | $51.94 | 4.01x | $156.27 | $254.3K | 6.9K | 2.2K |
| 2017 | $546.89 | $119.94 | 4.56x | $426.95 | $456.8K | 9.2K | 2.9K |
| 2018 | $514.53 | $114.50 | 4.49x | $400.03 | $569.3K | 9.2K | 2.7K |
| 2019 | $541.00 | $115.81 | 4.67x | $425.19 | $430.7K | 8.3K | 2.4K |
| 2020 | $182.24 | $41.06 | 4.44x | $141.18 | $354.4K | 8.6K | 2.6K |
| 2021 | $159.51 | $36.12 | 4.42x | $123.39 | $344.9K | 8.5K | 2.6K |
| 2022 | $174.11 | $37.84 | 4.60x | $136.27 | $256.2K | 7.3K | 2.6K |
| 2023 | $172.28 | $31.11 | 5.54x | $141.17 | $210.3K | 6.7K | 2.3K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 9.0K | $743.5K | $82.22 | 3.66x |
| J2505 | Injection, pegfilgrastim, 6 mg | 159 | $507.2K | $3.2K | 3.77x |
| G9678 | Oncology Care Model service | 2.4K | $385.6K | $158.04 | 1.01x |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | 3.1K | $309.5K | $98.49 | 6.68x |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | 3.2K | $260.4K | $80.42 | 3.60x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 4.1K | $212.6K | $51.88 | 3.84x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 12.4K | $112.0K | $9.01 | 3.71x |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | 773 | $91.3K | $118.06 | 3.39x |
| 80053 | Blood test, comprehensive group of blood chemicals | 7.8K | $87.5K | $11.25 | 5.21x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 1.7K | $83.7K | $49.89 | 5.87x |
| J9310 | Injection, rituximab, 100 mg | 119 | $79.3K | $666.60 | 3.15x |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | 438 | $66.1K | $150.96 | 3.60x |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | 823 | $45.3K | $55.05 | 3.67x |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 2.9K | $42.2K | $14.38 | 6.11x |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 1.7K | $36.7K | $22.09 | 6.56x |
| 38222 | Bone marrow biopsy and aspiration | 210 | $21.5K | $102.48 | 5.10x |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | 168 | $20.7K | $123.34 | 3.58x |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | 341 | $19.0K | $55.80 | 3.60x |
| 83615 | Lactate dehydrogenase (enzyme) level | 3.5K | $18.4K | $5.25 | 5.01x |
| 99239 | Hospital discharge day management, more than 30 minutes | 202 | $16.7K | $82.74 | 3.59x |
This provider submits charges 4.02 times higher than what Medicare actually pays.
A markup ratio of 4.02x means for every $100 Medicare pays, this provider initially charges $402. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data